Trial Profile
Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2013
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms Z-SEA-SIDE
- 20 Sep 2010 New trial record